Multiomic analysis reveals cell-type-specific molecular determinants of COVID-19 severity
Sai Zhang(Stanford University), M Snyder(Stanford University), Derya Unutmaz(Czech Academy of Sciences, Institute of Microbiology), Calum Harvey(University of Sheffield), Simone Furini(University of Siena), Francesca Fava(University of Siena), Thomas Julian(University of Sheffield), Mark M. Davis(Howard Hughes Medical Institute), J. Kenneth Baillie(Roslin Institute), Ilia Sarah Timpanaro(University Medical Center Utrecht), Johnathan Cooper‐Knock(University of Sheffield), Peng Gao(Stanford University), Xiaotao Shen(Nanyang Technological University), Elisa Frullanti(University of Siena), Philip S. Tsao(VA Palo Alto Health Care System), Alessandra Renieri(University of Siena), Kevin Kenna(University Medical Center Utrecht), Annika K. Weimer(Stanford Medicine), Minyi Shi(Stanford Medicine), Lina Kozhaya(Jackson Laboratory)
Cited by 37
Related Papers
Identification of a major co-receptor for primary isolates of HIV-1
|Nature|1996|3.7k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global Analysis of Protein Activities Using Proteome Chips
|Science|2001|1.9k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k